Brief: Sigilon Therapeutics Announces Pricing Of Upsized IPO
Dec 4 (Reuters) - Sigilon Therapeutics, Inc. SGTX.O :
* SIGILON THERAPEUTICS ANNOUNCES PRICING OF UPSIZED INITIAL
PUBLIC
OFFERING
* PRICED 7 MILLION SHARES OFFERING AT $18.00 PER SHARE
* SIGILON'S COMMON STOCK IS EXPECTED TO BEGIN TRADING ON
NASDAQ
GLOBAL MARKET ON DECEMBER 4, 2020 UNDER SYMBOL "SGTX."
Source text for Eikon: ID:nGNX4D4z53
Further company coverage: SGTX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Sigilon Therapeutics
See all newsSigilon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Sigilon Therapeutics Inc expected to post a loss of $4.71 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Micron, Greenbrier, Immunome
Sigilon jumps on Eli Lilly's buyout deal to expand diabetes treatments
U.S. STOCKS ON THE MOVE-Sigilon, Netflix, RenovoRx